Enterprise technology vendors are racing to make AI work against the structured and relational data inside databases, data ...
GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.
Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...
Materials databases lie at the heart of future data-driven discovery in energy-related fields, say researchers from Tohoku ...
Learn how Power BI Analytics in Microsoft BI uses data modeling, DAX, Power Query M, and a data gateway to build secure, ...
Materials databases lie at the heart of future data-driven discovery in energy-related fields, say researchers.
OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...
Kumo Launches KumoRFM-2, A Foundation Model Built to Replace Traditional Enterprise Machine Learning
Kumo has unveiled KumoRFM-2, a next-generation foundation model designed specifically for structured enterprise data—marking ...
By Juby Babu April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge ...
Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...
The next important milestone for AI research is to automate model development. Every advance in reasoning, language, and perception is, in some sense, a step toward that goal. However, the path to ...
The first new model to come out of Meta Superintelligence Lab following the company’s reorganization of its AI efforts, Muse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results